Chemical investigation of the marine sponge-derived fungal strain Aspergillus sp. IMBC-FP2.05 resulted in
isolation of five compounds, including JBIR-74 (1), homogentisic acid (2), methyl (2,5-dihydroxyphenyl)acetate (3), 3-
chloro-2,5-dihydroxybenzyl alcohol (4), and p-hydroxybenzaldehyde (5). Their chemical structures were identified by
comprehensive analyses of the 1D and 2D NMR and mass spectra in comparison with the previously reported data.
Furthermore, nitric oxide (NO) inhibitory effects of the isolated compounds in LPS-stimulated RAW264.7 cells were
also reported.
5 trang |
Chia sẻ: thuyduongbt11 | Ngày: 17/06/2022 | Lượt xem: 543 | Lượt tải: 0
Bạn đang xem nội dung tài liệu Anti-inflammatory metabolites from a marine sponge-associated fungus Aspergillus sp. IMBC-FP2.05, để tải tài liệu về máy bạn click vào nút DOWNLOAD ở trên
Cite this paper: Vietnam J. Chem., 2021, 59(1), 52-56 Article
DOI: 10.1002/vjch.202000099
52 Wiley Online Library © 2021 Vietnam Academy of Science and Technology, Hanoi & Wiley-VCH GmbH
Anti-inflammatory metabolites from a marine sponge-associated fungus
Aspergillus sp. IMBC-FP2.05
Tran Hong Quang1*, Le Thi Vien1, Le Ngoc Anh1, Nguyen Thi Thanh Ngan2, Tran Thi Hong Hanh1,
Nguyen Xuan Cuong1, Nguyen Hoai Nam1, Chau Van Minh1
1Institue of Marine Biochemistry, Vietnam Academy of Science and Technology (VAST), 18 Hoang Quoc
Viet, Cau Giay, Hanoi 10000, Viet Nam
2Institue of Genome Research, VAST, 18 Hoang Quoc Viet, Cau Giay, Hanoi 10000, Viet Nam
Submitted June 17, 2020; Accepted July 15, 2020
Abstract
Chemical investigation of the marine sponge-derived fungal strain Aspergillus sp. IMBC-FP2.05 resulted in
isolation of five compounds, including JBIR-74 (1), homogentisic acid (2), methyl (2,5-dihydroxyphenyl)acetate (3), 3-
chloro-2,5-dihydroxybenzyl alcohol (4), and p-hydroxybenzaldehyde (5). Their chemical structures were identified by
comprehensive analyses of the 1D and 2D NMR and mass spectra in comparison with the previously reported data.
Furthermore, nitric oxide (NO) inhibitory effects of the isolated compounds in LPS-stimulated RAW264.7 cells were
also reported.
Keywords. Aspergillus, marine-derived fungus, diketopiperazine, phenolic, nitric oxide.
1. INTRODUCTION
The Aspergillus genus comprises of more than 300
species occurring in various habitats,[1] of which the
marine-derived species have been shown to produce
various types of secondary metabolites, including
alkaloids, phenolics, terpenoids, and peptides with
interesting biological effects such as cytotoxic,
antimicrobial, and anti-inflammatory activities.[2]
However, little is known about the chemical
constituents and biological activities of Aspergillus
aculeatinus so far, except that a strain isolated from
Taxus chinensis var. mairei has been reported to
produce the anticancer drug taxol.[3] In our
continuing search for secondary metabolites from
the Vietnamese marine-derived fungi,[4,5] we found
that an EtOAc extract of the fungal strain
Aspergillus sp. IMBC-FP2.05 displays NO
inhibitory effects in LPS-stimulated RAW264.7
cells. In the present study, we report isolation and
structural elucidation of five secondary metabolites
from the EtOAc extract of the fermentation culture
of the fungal strain Aspergillus sp. IMBC-FP2.05. In
addition, NO inhibitory effects of the isolated
metabolites in LPS-stimulated RAW264.7 cells were
also evaluated.
2. MATERIAL AND METHODS
2.1. Fungal material
The fungal strain IMBC-FP2.05 was isolated from
an unidentified sponge collected from Quang Nam
sea, Vietnam during May, 2019. After sterilizing the
surface, the sponge sample was cut into small pieces
and ground using a sterile mortar and pestle and
mixed with sterile seawater. A portion of the sample
was processed using the spread plate method in
potato dextrose agar (PDA) medium containing
seawater. The plate was incubated at 25 oC for 15
days. After sub-culturing the isolates several times,
the final pure cultures were selected and preserved at
-80 oC. The strain was identified by DNA
amplification and analysis of the ITS region of the
rDNA sequence. A GenBank search using the ITS
rDNA gene of IMBC-FP2.05 revealed that
Aspergillus aculeatinus CBS 121060 (NR 135417.1)
is the closest match, with 99 % sequence identity.
Thus, the fungal strain IMBC-FP2.05 was identified
as Aspergillus sp.
2.2. General experimental procedures
Optical rotations were determined using a Jasco P-
2000 digital polarimeter. The NMR spectra were
recorded on Bruker AVANCE III HD 500 FT-NMR
spectrometer. ESIMS data were obtained using an
Vietnam Journal of Chemistry Tran Hong Quang et al.
© 2021 Vietnam Academy of Science and Technology, Hanoi & Wiley-VCH GmbH www.vjc.wiley-vch.de 53
ESI Q-TOF MS/MS system (AB SCIEX Triple).
TLC was performed on Kieselgel 60 F254 (Merck) or
RP-18 F254s (Merck) plates. Column chromatography
was performed on silica gel (Kieselgel 60, 70-230
mesh and 230-400 mesh, Merck) and YMC RP-18
resins. Preparative high-performance liquid
chromatography (HPLC) was performed on an
Agilent 1200 Preparative HPLC System.
2.3. Fermentation and extraction
The fungal strain Aspergillus sp. IMBC-FP2.05 was
grown on 80 replicate 2L-Erlenmeyer flasks (each
flask contained 100 mL of PDA mixed with 3 %
NaCl). The seed cultures (2 mL) of the fungal strain
was added to the growing media and incubated at 25
oC for 20 days. Subsequently, the fungal biomass
was extracted with EtOAc (20 L x three times) to
provide an organic phase which was further
concentrated under reduced pressure to give a
residue (8.25 g).
2.4. Isolation and identification
The EtOAc extract of Aspergillus sp. IMBC-FP2.05
was introduced to reversed phase (RP) C18 flash
column chromatography (CC), using a stepwise
gradient elution of 20, 40, 60, 80, and 100 % MeOH
in H2O to give six fractions (F1-F6), respectively. F1
was subjected to sephadex LH-20 CC, eluting with
MeOH-H2O (1:2, v/v) to provide subfractions F1.1-
F1.4). F1.4 was then purified by RP C18 prep. HPLC,
using an isocratic elution of acetonitrile in H2O (7:93,
v/v) over 60 min to release 2 (24 mg) and 3 (11 mg).
Fraction F2 was separated by Sephadex LH-20 CC,
using MeOH-H2O (1:2, v/v) as eluent to provide six
subfractions (F2.1–F2.6). Compound 5 (14 mg) was
isolated from the subfraction F2.5 by silica gel CC,
using CH2Cl2-MeOH (10:1, v/v) as a mobile phase.
F2.6 was purified through a RP C18 prep. HPLC,
using acetonitrile in H2O (7:93, v/v) over 60 min to
afford 4 (1.5 mg). F3 was fractionated by sephadex
LH-20 CC, eluting with MeOH-H2O (2:1, v/v) to
provide subfractions F3.1 and F3.2. Subfraction F3.1
was separated by silca gel CC, eluting with CH2Cl2-
MeOH (15:1, v/v) to provide F3.1.1 and F3.1.2.
From the subfraction F3.1.1, compound 1 (20 mg)
was obtained by RP C18 CC, using acetone-H2O (1:2,
v/v) as a mobile phase.
JBIR-74 (1): White, amorphous powder;
C12H16N4O2, M = 248; ESIMS: m/z 249 [M+H]+; 1H
(CD3OD, 500 MHz) and 13C NMR data (CD3OD,
125 MHz), see table 1.
Homogentisic acid (2): White, amorphous
powder; C8H8O4, M = 168; ESIMS: m/z 169 [M+H]+;
1H (CD3OD, 500 MHz) and 13C NMR data (CD3OD,
125 MHz), see table 2.
Methyl (2,5-dihydroxyphenyl)acetate (3): White,
amorphous powder; C9H10O4, M = 182; ESIMS: m/z
183 [M+H]+; 1H (CD3OD, 500 MHz) and 13C NMR
data (CD3OD, 125 MHz), see table 2.
3-Chloro-2,5-dihydroxybenzyl alcohol (4):
White, amorphous powder; C7H7ClO3, M = 174;
ESIMS: m/z 175 [M+H]+; 1H (CD3OD, 500 MHz)
and 13C NMR data (CD3OD, 125 MHz), see table 2.
p-Hydroxybenzaldehyde (5): Pale yellow,
amorphous powder; C7H6O2, M = 122; ESIMS: m/z
123 [M+H]+; 1H (CD3OD, 500 MHz) and 13C NMR
data (CD3OD, 125 MHz), see table 2.
2.5. Anti-inflammatory assay
Effects of the isolated compounds toward NO
overproduction in LPS-stimulated RAW264.7 cells
were evaluated using the Griess assay as previously
described.[4]
3. RESULTS AND DISCUSSION
Compound 1 was obtained as a white, amorphous
powder. Its molecular formula was established as
C12H16N4O2 by a protonated molecular ion [M+H]+
at m/z 249 in the ESIMS in combination with an
analysis of the 1H and 13C NMR spectra. The 1H
NMR spectrum exhibited signals of three olefinic
protons at H 6.71 (s, H-3), 7.36 (s, H-5), and 7.79
(s, H-6) which showed HSQC correlations with C
107.0 (C-3), 119.8 (C-5), and 137.3 (C-6),
respectively in the HSQC spectrum. In the HMBC
spectrum, correlations observed from H-5 to C-4
and C-6 and from H-6 to C-4 and C-5 revealed the
presence of an imidazole ring in the molecule
(Figure 1). H-5 additionally exhibited an HMBC
correlation with C-3, while H-3 was found to have
HMBC correlations with an amide carbonyl carbon
at C 162.6 (C-1), a non-protonated olefinic carbon
at C 125.2 (C-2), and C-4, suggesting the presence
of a 2-amino-3-(1H-imidazol-5-yl)acrylic acid unit.[6]
In the 1H NMR spectrum, signals for one primary
methyl at H 1.01 (t, J = 7.5 Hz, H3-5) and one
secondary methyl at H 0.92 (d, J = 6.5 Hz, H3-6)
were also observed. In addition, a down-field shifted
proton signal at H 4.19 (H-2) showed an HSQC
correlation with C 60.4 (C-2), suggesting the
presence of a nitromethine group. HSQC
interactions observed between a proton at H 2.07
(H-3) and an aliphatic carbon at C 41.9 (C-3) and
between two protons at H 1.52/1.35 (each m, H2-4)
and a carbon at C 26.5 (C-4) allowed to point out
Vietnam Journal of Chemistry Anti-inflammatory metabolites from
© 2021 Vietnam Academy of Science and Technology, Hanoi & Wiley-VCH GmbH www.vjc.wiley-vch.de 54
Figure 1: Chemical structures of 1-5 and selected HMBC correlations of 1, 3, and 4
the appearance of one methine and one methylene
group, respectively. In the HMBC spectrum,
correlations observed from H3-5 to C-3 and C-4,
from H3-6 to C-2, C-3, and C-4, and from H-3 to an
amide carbonyl carbon at C 167.9 (C-1) and C-2
revealed that 1 possesses an isoleucine as a partial
structure.[6] The conjunction of the 2-amino-3-(1H-
imidazol-5-yl)acrylic acid and isoleucine units was
deduced by HMBC correlations from H-2 to C-1
and from H-3 to C-1. The Z geometry of the 2,3-
double bond was identified based on the W type
long range correlation from H-3 to C-1.[6]
Subsequently, the structure of 1 was confirmed by
the good agreement when comparing its NMR data
with those of the reported diketopiperazine alkaloid,
JBIR-74.[6] On the basis of the spectroscopic
analysis, compound 1 was identified as JBIR-74.
Table 1: 1H and 13C NMR data for compound 1
Position C#
1
Ca,b Ha,c (mult., J in Hz)
1 166.8 167.9 -
2 59.2 60.4 4.19 (d, 2.0)
3 40.7 41.9 2.07 (m)
4 25.4 26.5 1.52 (m), 1.35 (m)
5 12.8 12.2 1.01 (t, 7.5)
6 11.0 14.0 0.92 (d, 6.5)
1 161.4 162.6 -
2 124.0 125.2 -
3 105.8 107.0 6.71 (s)
4 137.0 138.2 -
5 118.6 119.8 7.36 (s)
6 136.1 137.3 7.79 (s)
aRecorded in CD3OD, b125 MHz, c500 MHz
#δC of JBIR-74 in CD3OD.[6]
Compound 2 was isolated as a white, amorphous
powder, with the molecular C8H8O4 as deduced by a
quasi-molecular ion m/z 169 [M+H]+ in the ESIMS.
The 1H NMR spectrum showed signals characteristic
of an ABX spin system [H 6.66 (d, J = 8.5 Hz, H-3),
6.57 (dd, J = 2.5, 8.5 Hz, H-4), and 6.64 (d, J = 2.5
Hz, H-6)] and a singlet of a methylene group at H
3.55 (s, H2-7). The 13C NMR spectrum contained
eight signals, including one carbonyl carbon at C
176.2 (C-8), six sp2 carbons of a 1,2,5-trisubstituted
benzene ring of which two were oxygenated at C
149.6 (C-2) and 151.0 (C-5), and one sp3 carbon at
C 36.6 (C-7). Comparison of the 1H and 13C NMR
data of 2 with those of the reported phenylacetic acid
analog, homogentisic acid revealed the good match,
suggesting the similarity of both structures.[7]
Therefore, compound 2 was determined to be
homogentisic acid.
Compound 3 was obtained as a white,
amorphous powder. Comparison of the 1H and 13C
NMR data of 3 with those of 2 revealed the close
similarity, except for the additional presence of a
methoxy group in 3 at H 3.69 (s)/C 52.3 located at
the carbonyl carbon position. This was supported by
observation of an HMBC correlation from the proton
signal of the methoxy group at H 3.69 to the
carbonyl carbon signal at C 174.6 (C-8) in the
HMBC spectrum. Thus, the structure of 3 was
elucidated as methyl (2,5-dihydroxyphenyl)acetate.[8]
Compound 4 was purified as a white, amorphous
powder and its molecular formula was established as
C7H7ClO3 based on the presence of a protonated
molecular ion [M+H]+ at m/z 175, along with
analysis of its 1H and 13C NMR spectra. In the 1H
NMR spectrum, characteristic signals of two meta-
coupling protons at H 6.69 and 6.75 (each d, J = 3.0
Hz, H-4 and H-6) were observed, suggesting the
presence of a 1,2,3,5-tetrasubstituted aromatic ring.
In addition, a singlet signal of an oxymethylene
group at H 4.64 (s, H2-7) was also observed in the
1H NMR spectrum. The 13C NMR and HSQC
spectra showed signals of six sp2 of which two non-
Vietnam Journal of Chemistry Tran Hong Quang et al.
© 2021 Vietnam Academy of Science and Technology, Hanoi & Wiley-VCH GmbH www.vjc.wiley-vch.de 55
protonated carbons at C 132.1 (C-1) and 121.9 (C-3)
and two oxygenated carbons at C 144.4 (C-2) and
151.8 (C-5), along with one sp3 carbon at C 61.2
(C-7). The location of the oxymethylene group at C-
1 position was deduced by an HMBC correlation
from H 4.64 (H2-7) to C-1, C-2, and C-6 in the
HMBC spectrum (Figure 1). The remaining non-
protonated sp2 carbon, with the more up-field
chemical shift at C 121.9 compared with that of C-1
(C 132.1) was suggested to be a location of a
halogen atom. Accordingly, comparison of the 1H
and 13C NMR data of 4 with those of a previously
reported chlorobenzyl derivative, 3-chloro-2,5-
dihydroxybenzyl alcohol resulted in the good match,
suggesting that the structures of both compounds are
identical and the location of a chlorine atom at C-3
position.[9] Assignment of all the positions of 4 was
further confirmed by detailed analysis of the HMBC
spectrum as shown in figure 1. Thus, the overall
structure of 4 was concluded to be 3-chloro-2,5-
dihydroxybenzyl alcohol.
Table 2: 1H- and 13C-NMR data for compounds 2-5
Pos. C#1 2 C#2 3 C#3 4 C#4 5
Ca,b Ha,c Ca,b Ha,c Ca,b Ha,c Ca,b Ha,c
1 124.3 123.6 - 124.3 123.2 - 132.0 132.1 - 129.9 130.3 -
2 150.4 149.6 - 148.2 149.6 - 144.3 144.4 - 132.5 133.4 7.80 (d, 9.0)
3 117.4 116.8 6.66 (d, 8.5) 115.8 116.7 6.65 (d, 8.5) 121.8 121.9 - 116.0 116.9 6.94 (d, 9.0)
4 116.0 115.6 6.57 (dd, 2.5,
8.5)
114.7 115.7 6.57 (dd, 3.0,
8.5)
115.4 115.5 6.69 (d, 3.0) 161.6 165.1 -
5 151.6 151.0 - 150.0 151.1 - 151.7 151.8 - 116.0 116.9 6.94 (d, 9.0)
6 119 118.6 6.64 (d, 2.5) 117.9 118.6 6.62 (d, 3.0) 114.5 114.5 6.75 (d, 3.0) 132.5 133.4 7.80 (d, 9.0)
7 37.7 36.6 3.55 (s) 35.5 36.5 3.57 (s) 61.1 61.2 4.64 (s) 191.2 192.8 9.78 (s)
8 177.0 176.2 - 172.2 174.6 -
OCH3 51.8 52.3 3.69 (s)
aRecorded in CD3OD, b125 MHz, c500MHz, multiplicity and coupling constants (Hertz) are given in parentheses; #1δC
of homogentisic acid in CD3OD;[7] #2δC of methyl (2,5-dihydroxyphenyl)acetate in DMSO-d6;[8] #3δC of 3-chloro-2,5-
dihydroxybenzyl alcohol in CD3OD;[9] #4C of p-hydroxybenzaldehyde in CDCl3.[10]
Compound 5 was given as a pale yellow,
amorphous powder. Its molecular formula was
determined to be C7H6O2 by the ESIMS and the 1H
and 13C NMR spectroscopic data. The 1H NMR
spectrum contained signals of two pairs of ortho-
coupling aromatic protons at H 7.80 (each d, J = 9.0
Hz, H-2 and H-6) and 6.94 (d, J = 9.0 Hz, H-3 and
H-5), suggesting the presence of a 1,4-disubstituted
benzene ring. The 1H NMR additionally showed a
far down-field shifted signal of at H 9.78 (s, H-7),
implying the presence of an aldehyde group. The 13C
NMR spectrum displayed seven carbon signals,
including one aldehyde carbon at C 192.8 (C-7) and
six carbons of the para-substituted aromatic ring.
This spectroscopic data suggested that 5 possesses
the benzaldehyde skeleton type. Accordingly, the 1H
and 13C NMR data of 5 were shown to be similar
with those of the reported p-hydroxybenzaldehyde,
indicating both compounds have the identical
structures.[10] Thus, the structure of 5 was established
as p-hydroxybenzaldehyde.
The in vitro anti-inflammatory effects of the
isolated compounds 1-5 were evaluated using LPS-
induced NO overproduction in RAW264.7 cells,
with the concentration range up to 80 M.[11] The
result revealed that two 2,5-dihydroxyphenylacetic
acid derivatives, including shomogentisic acid (2)
and methyl (2,5-dihydroxyphenyl)acetate (3) among
the tested compounds, showed the most inhibitory
effects against NO overproduction, with IC50 values
of 28.2 and 14.2 M, respectively (yable 3). The
chloro-benzyl alcohol (4) exhibited an NO inhibitory
effect (IC50 = 41.8 M) which was comparable with
that of the positive control, NG-Monomethyl-L-
arginine (L-NMMA) (IC50 = 44.5 M). Compounds
1 and 5 moderately inhibited NO overproduction in
LPS-stimulated RAW264.7 cells, with IC50 values of
79.7 and 62.4 M, respectively.
Table 3: Nitric oxide inhibitory effects of
compounds 1-7
Compound IC50 (µM)a
1 79.72.4
2 28.23.0
3 14.21.5
4 41.83.8
5 62.42.9
L-NMMAb 44.56.2
aThe values are mean SD (n = 3); bPositive control.
Vietnam Journal of Chemistry Anti-inflammatory metabolites from
© 2021 Vietnam Academy of Science and Technology, Hanoi & Wiley-VCH GmbH www.vjc.wiley-vch.de 56
In conclusion, our chemical study of the marine-
derived fungal strain Aspergillus sp. IMBC-FP2.05
led to the isolation of five metabolites: JBIR-74 (1),
homogentisic acid (2), methyl (2,5-
dihydroxyphenyl)acetate (3), 3-chloro-2,5-
dihydroxybenzyl alcohol (4), and p-
hydroxybenzaldehyde (5). It is noted that this is the
first time to report the in vitro anti-inflammatory
effects of compounds 1, 3, and 4.
Acknowledgment. This work was financially
supported by Vietnam Academy of Science and
Technology (VAST04.05/19-20).
REFERENCES
1. R. A. Samson, C. M. Visagie, J. Houbraken, S.-B.
Hong, V. Hubka, C. H. Klaassen, G. Perrone, K. A.
Seifert, A. Susca, J. B. Tanney. Phylogeny,
identification and nomenclature of the genus
Aspergillus, Stud. Mycol., 2014, 78, 141-173.
2. Y. M. Lee, M. J. Kim, H. Li, P. Zhang, B. Bao, K. J.
Lee, J. H. Jung. Marine-derived Aspergillus species
as a source of bioactive secondary metabolites, Mar.
Biotechnol., 2013, 15, 499-519.
3. W. Qiao, F. Ling, L. Yu, Y. Huang, T. Wang.
Enhancing taxol production in a novel endophytic
fungus, Aspergillus aculeatinus Tax-6, isolated from
Taxus chinensis var. mairei, Fungal Biol., 2017, 121,
1037-1044.
4. T. H. Quang, D. C. Kim, P. Van Kiem, C. Van Minh,
N. X. Nhiem, B. H. Tai, P. H. Yen, N. Thi Thanh
Ngan, H. J. Kim, H. Oh. Macrolide and phenolic
metabolites from the marine-derived fungus
Paraconiothyrium sp. VK-13 with anti-inflammatory
activity, J. Antibiot., 2018, 71, 826-830.
5. T. H. Quang, N. X. Nhiem, B. H. Tai, P. H. Yen, D.
T. Dung, N. T. T. Ngan, H. Le Tuan Anh, C. Van
Minh, P. Van Kiem. Secondary metabolites from the
marine-derived fungus Paraconiothyrium sp. VK-13,
Vietnam J. Chem., 2018, 56, 434-439.
6. M. Takagi, K. Motohashi, K. Shin-ya. Isolation of 2
new metabolites, JBIR-74 and JBIR-75, from the
sponge-derived Aspergillus sp. fS14, J. Antibiot.,
2010, 63, 393-395.
7. S.-L. Wang, H.-T. Li, L.-J. Zhang, Z.-H. Lin, Y.-H.
Kuo. Conversion of squid pen to homogentisic acid
via Paenibacillus sp. TKU036 and the antioxidant
and anti-Inflammatory activities of homogentisic acid,
Mar. Drugs, 2016, 14, 183.
8. N. Lebouvier, V. Jullian, I. Desvignes, S. Maurel, A.
Parenty, D. Dorin-Semblat, C. Doerig, M. Sauvain, D.
Laurent. Antiplasmodial activities of homogentisic
acid derivative protein kinase inhibitors isolated from
a Vanuatu marine sponge Pseudoceratina sp., Mar.
Drugs, 2009, 7, 640-653.
9. T. F. N. Kwong, L. Miao, X. Li, P. Y. Qian. Novel
antifouling and antimicrobial compound from a
marine-derived fungus Ampelomyces sp., Mar.
Biotechnol., 2006, 8, 634-640.
10. D. S. Jang, A.-R. Han, G. Park, G.-J. Jhon, E.-K. Seo.
Flavonoids and aromatic compounds from the
rhizomes of Zingiber zerumbet, Arch. Pharm. Res.,
2004, 27